4D Molecular Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
AKRO
Akero Therapeutics, Inc. |
$45.30 | $3.61 B | -12.18 | 69 |
IPSC
Century Therapeutics, Inc. |
$0.56 | $48.25 M | -2.07 | 140 |
CCCC
C4 Therapeutics, Inc. |
$1.26 | $89.11 M | -0.85 | 110 |
CGEM
Cullinan Oncology, Inc. |
$7.85 | $462.97 M | -2.83 | 111 |
GOSS
Gossamer Bio, Inc. |
$1.15 | $261.40 M | -5.23 | 144 |
EWTX
Edgewise Therapeutics, Inc. |
$13.99 | $1.47 B | -9.02 | 117 |
KRON
Kronos Bio, Inc. |
$0.67 | $41.00 M | -0.63 | 8 |
MLYS
Mineralys Therapeutics, Inc. |
$15.84 | $1.03 B | -4.28 | 51 |
BMEA
Biomea Fusion, Inc. |
$1.39 | $52.23 M | -0.39 | 79 |
BCEL
Atreca, Inc. |
$0.09 | $3.57 M | -0.04 | 90 |
FIXX
Homology Medicines, Inc. |
$0.93 | $3.02 M | -0.03 | 7 |
BDTX
Black Diamond Therapeutics, Inc. |
$1.98 | $112.59 M | 33 | 24 |
RVMD
Revolution Medicines, Inc. |
$37.73 | $7.03 B | -9.41 | 616 |
STOK
Stoke Therapeutics, Inc. |
$9.44 | $515.39 M | 11.51 | 128 |
PASG
Passage Bio, Inc. |
$0.36 | $22.37 M | -0.35 | 60 |
NVCT
Nuvectis Pharma, Inc. |
$9.68 | $202.25 M | -8.57 | 13 |
REPL
Replimune Group, Inc. |
$8.42 | $649.07 M | -2.74 | 331 |
LYRA
Lyra Therapeutics, Inc. |
$4.44 | $294.23 M | -0.08 | 30 |
TCRR
TCR2 Therapeutics Inc. |
$1.48 | $58.11 M | -0.35 | 58 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
